Why Immunomedics Stock Skyrocketed 125% in April

Shares of biotech Immunomedics (NASDAQ: IMMU) skyrocketed 125% in April, according to data from S&P Global Market Intelligence. 

By comparison, the S&P 500 index returned 12.8% last month, as the market made a strong comeback from March's big coronavirus-driven sell-off, which drove the index (including dividends) down 12.4%.

So far in May, through Monday, Immunomedics stock is up just over 8%, while the broader market has returned less than 1%.  

Continue reading

Source Fool.com